Moderna vaccine trial pleases investors, EBIT...

US and Chinese experts meet to discuss mitigating AI risks despite an ongoing tech rivalry, and US megadonors are largely backing Republicans in this midterm election season. Plus, Prime Minister Mark Carney strikes out on his pitch for a “unique alliance” between Canada and the ...  عرض المزيد

Tech stocks fell yesterday as markets reacted to ongoing talk of an AI apocalypse, industrial America is contending with a fresh wave of supply chain inflation, and foreign investors are now buying more US stocks than government bonds. Plus, China has implemented sweeping new con ...  عرض المزيد

There’s more positive news on the vaccine front, companies are raising dividends, and earnings guidance has been strong. Corporate America seems to think we’ve gotten past the worst effects of the pandemic, but have we?

Plus Bitcoin nearing the $19,000 mark after surging ...

Carl Quintanilla, Jim Cramer and David Faber discuss China’s property market crisis and the Federal Reserve's decision to keep current monetary stimulus in place for just a little bit longer. The Food and Drug Administration has authorized Pfizer and BioNTech’s Covid-19 booster s ...  عرض المزيد

Carl Quintanilla, Jim Cramer and David Faber discuss the surge in stocks. Markets getting a boost from blowout results from Goldman Sachs and Moderna’s vaccine news. Goldman Sachs crushing earnings estimates its biggest outperformance in nearly a decade. Revenue was more than ...

Chinese officials’ pledges to provide bolder support for economic growth are fuelling a rally in shares related to Chinese consumption, Chinese real estate, and Asian mining stocks. China beneficiaries in Europe also posted strong gains yesterday. Meanwhile, US equity markets ...